References in periodicals archive ?
Factors that could cause or contribute to such differences may include, but are not limited to, the risk of unanticipated administrative delays, risks relating to the integration of the technologies and businesses of QIAGEN and Digene, unanticipated expenditures, changing relationships with customers, suppliers and strategic partners, conditions of the economy and other factors described in the most recent reports on Form 20-F, Form 6-K and other periodic reports filed with or furnished to the Securities and Exchange Commission by QIAGEN and the most recent reports on Form 10-K, Form 10-Q, Form 8-K and other periodic reports filed by Digene with the Securities and Exchange Commission.
Digene and Qiagen had US sales of about $117 million and $150 million, respectively, in 2006.
Ruling in favor of Digene's request for dismissal, the Superior Court for the County of San Diego stated that there is "no actual controversy between Digene and Gen-Probe.
For this reason, Digene is proud to support this call to action and to sponsor European Cervical Cancer Prevention Week.
Schatz, Chief Executive Officer of QIAGEN said, "We are pleased with the overwhelming support from both QIAGEN and Digene shareholders and believe their commitment is a testament to the significant benefits this combination creates.
Over the last year, Abbott Laboratories and PE Biosystems have entered into strategic marketing relationships with Digene to access Hybrid Capture for the diagnostic and pharmaceutical-screening markets.
How does the Digene HPV Test differ from other solutions on the market?
The Digene HPV Test detects the recognized cause of cervical cancer -- HPV.
In the decision, the court did not adopt all of the positions argued by Digene, Pam Rasmussen, company spokesperson, stated: "We clearly disagree with the court's decision, and continue to believe in the strength of our claims and remain committed to vigorously enforcing our intellectual property rights.
Cytyc Corporation (Nasdaq:CYTC) today announced that Digene Corporation (Nasdaq:DIGE) has terminated their definitive merger agreement.
Nasdaq: QGEN; Frankfurt, Prime Standard: QIA) today announced that its offer to exchange cash and stock for all outstanding shares of Digene Corporation expired as scheduled at 11:59 p.